• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. EQUINOXE REVERSE GLENOSPHERE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. EQUINOXE REVERSE GLENOSPHERE Back to Search Results
Catalog Number 320-01-38
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Migration (4003)
Patient Problems Joint Disorder (2373); No Code Available (3191)
Event Date 07/21/2017
Event Type  Injury  
Manufacturer Narrative
Pending evaluation.
 
Event Description
Revision of equinoxe components.
 
Manufacturer Narrative
Pending evaluation.Updated with catalog number and device description.
 
Event Description
Index surgery: (b)(6) 2014.Revision due to liner disengaging from tray.
 
Manufacturer Narrative
Upon review of all available information, the reported revision was likely the result of either incomplete seating of the humeral liner during implantation, forceful contact between the liner and the glenoid bone (scapular notching), or complete wear of the liner detaching from the humeral adapter tray.However, this cannot be confirmed because the devices were not available for evaluation and adequate information was not provided.This device was used for treatment, not diagnosis.Postoperative component loosening is a known complication associated with total shoulder arthroplasty.Per complications of total shoulder arthroplasty (1), postoperative component loosening was the number one most frequent complication of total shoulder arthroplasty, with a prevalence of 39% and 6.3% of all shoulders.There are anywhere from 5% to 42% revision rates (unrestrained and restrained implants).Loosening of the humeral and glenoid components is a common event, accounting for 39% of complications.Factors that have been associated with glenoid stability have included the preservation of the subchondral plate, concentric reaming of the glenoid, biomaterial design and selection, and glenohumeral mismatch of the prosthetic.This device is used for treatment not diagnosis.No information, asked not provided.(1) bohashi, k.I., et al.Complications of total shoulder arthroscopy.Journal of bone and joint surgery, 88:2279-2292, october 2006.
 
Event Description
It was reported that a patient who was initially had a total shoulder arthroplasty in (b)(6) 2014, experienced a revision due to the liner disengaging from the tray.Reportedly, the patient's health was stable post-op and there were no known concerns postoperatively.This is one of eleven products involved with the reported event and the associated manufacturer report numbers are 1038671-2018-00012, 1038671-2018-00013, 1038671-2018-00014, 1038671-2018-00015, 1038671-2018-00016, 1038671-2018-00017, 1038671-2018-00018, 1038671-2018-00019, 1038671-2018-00020 and 1038671-2018-00021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EQUINOXE REVERSE GLENOSPHERE
Type of Device
EQUINOXE REVERSE GLENOSPHERE
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66th court
gainesville FL 32653
MDR Report Key7147843
MDR Text Key95823612
Report Number1038671-2017-00937
Device Sequence Number1
Product Code KWT
Combination Product (y/n)N
PMA/PMN Number
K063569
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 05/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue Number320-01-38
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-